This panel was developed to measure the functional capability of natural killer (NK) cell subsets in rhesus macaques (Macaca mulatta). It includes markers to determine the frequency of cytokine secreting and cytotoxic NK cell subpopulations in peripheral blood mononuclear cell (PBMC) NEW data provided evidence that SIV-derived peptides could influence NK cell responses by modulating MHC Class I interactions with inhibitory killer cell immunoglobulin-like receptors (KIRs) of rhesus macaques. For example, Mamu-KIR3DL05 can be engaged by Mamu-A1*002 MHC Class I allele-bound SIVmac239 peptides, resulting in the inhibition of the cytolytic activity of Mamu-KIR3DL05 positive NK cells (1). Disruption of the differentiation of NK cells in rhesus macaques were reported after infection with SIVmac239 (2). However, it is not known whether all subsets of the NK cell population are equally affected. Here we developed a panel to support studies that address this issue. Our goal was to monitor the functional capability of NK cell subpopulations defined by the expression of Mamu-KIR3DL01 and Mamu-KIR3DL05 inhibitory receptors. Approximately 90% of the captive bred rhesus macaques of Indian origin express KIR3DL01 and >40% of the animals are positive for KIR3DL05 (3-5).
NEW data provided evidence that SIV-derived peptides could influence NK cell responses by modulating MHC Class I interactions with inhibitory killer cell immunoglobulin-like receptors (KIRs) of rhesus macaques. For example, Mamu-KIR3DL05 can be engaged by Mamu-A1*002 MHC Class I allele-bound SIVmac239 peptides, resulting in the inhibition of the cytolytic activity of Mamu-KIR3DL05 positive NK cells (1) . Disruption of the differentiation of NK cells in rhesus macaques were reported after infection with SIVmac239 (2) . However, it is not known whether all subsets of the NK cell population are equally affected. Here we developed a panel to support studies that address this issue. Our goal was to monitor the functional capability of NK cell subpopulations defined by the expression of Mamu-KIR3DL01 and Mamu-KIR3DL05 inhibitory receptors. Approximately 90% of the captive bred rhesus macaques of Indian origin express KIR3DL01 and >40% of the animals are positive for KIR3DL05 (3) (4) (5) .
In rhesus macaques, NK cells are primarily defined as CD8aa1CD3-lymphocytes (6,7). The overwhelming majority (>90%) of these cells express NKG2A/C receptor. The CD16 (FcRc III) and CD56 (N-CAM) differentiation markers define four NK cell subpopulations. In healthy animals the CD161 NK cells are primarily cytotoxic, the CD561 are predominantly cytokine-secreting, while CD16-CD562 NK cells can perform both functions (2) . In flow cytometric methods, the presence of intracellular granzyme B and up-regulation of the degranulation marker CD107a are used as indicators of cytotoxic capability. The cytokine-secreting ability of NK cells is determined by detection of IFN-c and TNF-a.
To assess the functional capability of the NK ell subsets we performed an 18-hour long in vitro stimulation assay using human 721.221 cells as stimulatory agents. To exclude the human cells in the gating strategy we used a nonhuman primate-specific antibody recognizing the hematopoietic marker CD45 antigen (clone D058-1283).
As we previously reported in OMIP-028 (8), the availability of antibodies recognizing certain rhesus-antigens is rather limited. For example, there is only one antibody Within the NK cell population, four subsets were identified using the KIR3DL01 and KIR3DL05 receptor expression pattern. All four subsets were further divided into CD161, CD561, and CD16-CD562 (DN) populations. (The third panel shows the KIR3D double negative population.) (C) Next, we defined the IFN-c1, TNF-a1, CD107a1 Granzyme B high (Q2), and CD107a1 Granzyme B low (Q3) subsets using (D) the matching non-stimulated sample within the CD161, and CD16-CD562 NK cell populations. (Panels in the C and D series shows the CD161 subset within the KIR3D double negative population.) (E) Functional subpopulations, as defined by the combined expression pattern of IFN-c1, TNF-a1, CD107a 1 Granzyme B high (Q2), and CD107a1 Granzyme B low (Q3) subsets were quantified by Boolean gating and displayed as a bar graph. Only subsets above 0.6% of the parent population, containing >10 events are displayed. None of the CD561 populations reached this cutoff level.
(clone Z199) specific to NKG2A (CD159a) in humans that cross-reacts with rhesus samples. It is noteworthy that this antibody binds both the activating NKG2C and the inhibitory NKG2A receptor in rhesus macaques (9) . Mamu-KIR3DL01 is recognized only by the monoclonal antibody NKVFS1. Mamu-KIR3DL05 is bound by several Mamu-A1*00201-restricted SIVmac239 epitope tetramers, among them the GY9 epitope loaded provides the best option as far as the staining is regarded (3).
Since a subset of CD20 positive cells in the blood of rhesus macaques express CD56 (Supporting Information Fig.  S1 ), and cytotoxic T cells express CD8a we included the CD20 and CD3 markers in the dump channel. Of the four anti-CD3 specific antibody clones (SP34-2, FN18, 10D12, and SK7) that are available commercially, we have had experience with clones SP34-2 and FN18. In our animal colony a small percentage of rhesus macaques express a CD3 isoform that is not recognized by the FN18 clone. Therefore, we tested several fluorochrome-conjugated forms of clone SP34-2 as detailed in the supplementary information (Supporting Information  Fig. S2 ).
There are numerous CD8a chain-specific clones in a wide variety of conjugates to choose from. We selected the BV711-conjugated RPA-T8 clone, because it provided good separation and had minimal spectral overlap with the other fluorochromes in the panel. Five CD16 cross-reacting clones are available commercially in multiple fluorochrome-conjugates. We have had excellent results with clone 3G8 in the past. For this panel we tested the FITC, Pacific Blue, BV711, and PerCPCy5.5 forms.
We tested two clones of CD56-specific antibodies labeled with either FITC (clone B159), PE-Cy7, or PerCPCy5.5 (clone NCAM16.2). Since we reserved the PE-Cy7 conjugate for the NKG2A/C and the FITC conjugate for the IFN-c-specific antibody we selected the PerCPCy5.5-labeled clone NCAM16.2.
The single known cross-reacting CD107a-specific antibody is available in multiple fluorochrome-labeled forms. We usually use the PE-conjugated form, however this channel was already reserved for Mamu-KIR3DL01. For this panel we evaluated the BV786 and the BV605 forms. While the BV786 conjugate did not yield the desired separation, the BV605 did. To quantify the level of intracellular granzyme B zymogen, we selected the monoclonal antibody GB11. As this protein is stored in copious amounts in cytoplasmic granules, we were able to choose a detector where cellular autofluorescence would be otherwise prohibitive for markers expressed at considerably lower quantities. We tested the BV510-labeled antibody and obtained excellent results. In rhesus macaques all circulating NK cells contain granzyme B. However, NK cells expressing the CD107a degranulation marker could be subdivided into granzyme B low and granzyme B high subpopulations (Fig. 1C and 1D : Q2 and Q3). We postulated that the cells with lower granzyme B content are the most active cytotoxic cells; therefore, the separate monitoring of the two populations is a worthwhile exercise (Fig. 1C-1E ). Finally, we selected the reagents to define the frequency of cytokine producing NK cell subsets. For IFN-c we tested the BV650 and FITC-conjugated variants of clone 4S.B3. The violet laser excitable conjugate delivered inferior staining compared to the FITC-labeled antibody, so we selected the latter one. For monitoring TNF-a secretion, we examined the PE-CF594 and the Alexa700-conjugated forms of clone MAb11.
As the considerably different size of CD107a 1 Granzyme low (Q3) subset within the KIR3DL01 1 CD161 and KIR3DL05 1 CD161 populations (2.19% vs. 9.22%) (Fig. 1E) demonstrates 
SIMILARITY TO PUBLISHED OMIPS
This rhesus macaque-specific panel shares a lot of similarities with OMIP-007 (10) and OMIP-027 (11) ( Table 1) . OMIP-007 was designed to analyze the maturation, homing, and activation phenotype of human KIR-defined NK cell subsets. OMIP-027 was developed to measure the functional capability of the total NK cell population in human samples. Our panel in essence is a combination and species-specific modification of the two panels. It enables the investigator to follow the function of up to five KIR3D and CD16 defined NK cell populations in individual rhesus macaques of Indian origin ( Table 2) .
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